Your browser doesn't support javascript.
loading
Evaluation of Antiviral Activity of Cyclic Ketones against Mayaro Virus.
Fernandes, Luciana S; da Silva, Milene L; Dias, Roberto S; da S Lucindo, Marcel S; da Silva, Ítalo E P; Silva, Cynthia C; Teixeira, Róbson R; de Paula, Sérgio O.
Afiliação
  • Fernandes LS; Molecular Immunovirology Laboratory, General Biology Department, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.
  • da Silva ML; Microbiology Department, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.
  • Dias RS; Molecular Immunovirology Laboratory, General Biology Department, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.
  • da S Lucindo MS; Molecular Immunovirology Laboratory, General Biology Department, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.
  • da Silva ÍEP; Molecular Immunovirology Laboratory, General Biology Department, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.
  • Silva CC; Microbiology Department, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.
  • Teixeira RR; Chemistry Department, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.
  • de Paula SO; Molecular Immunovirology Laboratory, General Biology Department, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.
Viruses ; 13(11)2021 10 21.
Article em En | MEDLINE | ID: mdl-34834929
ABSTRACT
Mayaro virus (MAYV) is a neglected arthropod-borne virus found in the Americas. MAYV infection results in Mayaro fever, a non-lethal debilitating disease characterized by a strong inflammatory response affecting the joints and muscles. MAYV was once considered endemic to forested areas in Brazil but has managed to adapt and spread to urban regions using new vectors, such as Aedes aegypti, and has the potential to cause serious epidemics in the future. Currently, there are no vaccines or specific treatments against MAYV. In this study, the antiviral activity of a series of synthetic cyclic ketones were evaluated for the first time against MAYV. Twenty-four compounds were screened in a cell viability assay, and eight were selected for further evaluation. Effective concentration (EC50) and selectivity index (SI) were calculated and compound 9-(5-(4-chlorophenyl]furan-2-yl)-3,6-dimethyl-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2))-dione (9) (EC50 = 21.5 µmol·L-1, SI = 15.8) was selected for mechanism of action assays. The substance was able to reduce viral activity by approximately 70% in both pre-treatment and post-treatment assays.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por Alphavirus / Alphavirus / Cetonas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por Alphavirus / Alphavirus / Cetonas Idioma: En Ano de publicação: 2021 Tipo de documento: Article